Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
William Blythe is a specialty chemical manufacturer based in the United Kingdom that focuses on the development and production of high-purity inorganic chemicals and advanced materials. Founded in 1845, the company provides essential components for the life sciences, electronics, and performance materials sectors, including iodine derivatives used in pharmaceutical contrast agents and catalysts for drug synthesis. They are notably active in the advanced materials space, producing graphene oxide and other functionalized nanomaterials for medical and industrial applications. As a subsidiary of Synthomer, William Blythe offers custom manufacturing and process development services to support global pharmaceutical supply chains. Their expertise lies in scaling complex inorganic chemical processes from laboratory to industrial volumes while maintaining rigorous quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on William Blythe.